TNFSF13B and metabolic dysfunction-associated steatohepatitis: The serum BAFF levels in NASH and CLD-C patients were significantly higher than those in NHCs (903 ± 206, 972 ± 366 vs. 690 ± 88 pg/ml, Fig. 3a).